Financing ·
NKGen Biotech, Inc. entered into a First Amendment to Equity and Business Loan Agreement with BDW Investments, LLC on…
NKGNNKGen Biotech, Inc.
NKGen Biotech, Inc. entered into a First Amendment to Equity and Business Loan Agreement with BDW Investments, LLC on July 13, 2026, modifying the terms of a $5 million multi-draw term loan. The amendment replaces the all-assets security agreement with a first priority perfected security interest in specific real estate collateral of the Borrower, and amends the definition of Senior Loan to include the AlpineBrook Capital GP I Limited Senior Convertible Loan Agreement. NKGen Biotech, Inc. is a biotechnology company focused on on-demand, on-site, personalized cell therapy.